Supreme Court order on free coronavirus testing by private institutions may hinder fight, say business leaders, health experts

The Supreme Court said on Wednesday private medical institutions should be playing a philanthropic role at a time of national crisis and it would not allow a situation where India’s poor could not afford a test for the virus

Reuters April 09, 2020 17:15:56 IST
Supreme Court order on free coronavirus testing by private institutions may hinder fight, say business leaders, health experts

New Delhi: A decision by the Supreme Court of India to make testing for coronavirus free places an unfair financial burden on medical firms and could see a reduction in testing, already among the world’s lowest, said business leaders and health experts.

The concern is that private medical firms, like many businesses in India are struggling financially, and could go under if they tested for free without financial assistance.

Supreme Court order on free <span class=coronavirus testing by private institutions may hinder fight say business leaders health experts" width="380" height="285" />

File image of the Supreme Court of India. Reuters

Kiran Mazumdar Shaw, executive chairperson of Biocon Limited, one of India’s biggest biotech firms, said private institutions could not be expected to operate on credit.

“Humanitarian in intent but impractical to implement - I fear testing will plummet,” Shaw said on Twitter on Thursday about the court judgement.

“These are small businesses they’re providing testing at cost and not profiteering. How will they pay their employees?”

The top court, responding to a public interest petition, said on Wednesday private medical institutions should be playing a philanthropic role at a time of national crisis and it would not allow a situation where India’s poor could not afford a test for the virus that is quickly spreading through the country.

It said the issue of reimbursing these laboratories for running the hundreds of thousands of tests for novel coronavirus that the world’s second most populous country urgently needs would be considered later on.

India has 5,734 cases of coronavirus and 166 deaths from COVID-19 , the respiratory disease caused by the virus, according to the ministry of health and family welfare, reflecting a jump of 460 cases over Wednesday.

The numbers are small compared to the United States, Italy and Spain and one of the reasons is that the country is testing a narrow range of the population, doctors say.

These include people who have travelled overseas, people in contact with them and are showing symptoms, health workers with symptoms, hospitalised patients with respiratory problems and those who came in contact with a confirmed patient.

On Wednesday, 13,143 samples were tested nationwide, the government-run Indian Council of Medical Research said, well behind the 20,000 people South Korea has been testing each day from its far smaller population.

Updated Date:

also read

'Come together to defeat BJP': Mamata Banerjee discusses Oppn unity, Pegasus row with Sonia and Rahul
Politics

'Come together to defeat BJP': Mamata Banerjee discusses Oppn unity, Pegasus row with Sonia and Rahul

Banerjee's visit during the ongoing Parliament's Monsoon Session assumes increased significance with the Opposition cornering the Centre on price rise, increasing cost of fuel and COVID-19 pandemic

India reports less than 30,000 new COVID-19 cases after over four months; total toll at 4.2 lakh
India

India reports less than 30,000 new COVID-19 cases after over four months; total toll at 4.2 lakh

As many as 29,689 new coronavirus infections took the country's tally of COVID-19 cases to 3,14,40,951. The national recovery rate improved to 97.39 percent

Over 3.09 crore unutilised vaccine doses available with states and private hospitals, says Centre
India

Over 3.09 crore unutilised vaccine doses available with states and private hospitals, says Centre

It said that more than 45.37 crore vaccine doses have been provided to states and UTs so far through all sources and a further 59,39,010 doses are in the pipeline